In a significant healthcare announcement, President Trump revealed a new Medicaid drug pricing model that will include all 50 states, aimed at reducing prescription drug costs for Medicaid recipients. This initiative is expected to save billions through the most favored nation pricing strategy, which ensures that all states benefit from lower drug prices. Several governors, including Gov. Tate Reeves, have expressed their support for this plan, emphasizing its importance in providing affordable medication to those in need. The administration claims that this new program is a critical step towards achieving substantial savings for Medicaid without compromising the quality of care.